News

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Could this be a new era of preventative cancer medicine?
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...
Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down ...
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...
SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, ...
U.S. economy is experiencing ‘death by a thousand cuts’, says Deutsche Bank, as confidence in national debt management erodes ...